Trial Profile
Prospective study of retinal nerve fibre layer thickness in alemtuzumab treated multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Feb 2016 New trial record